China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026)
China Pharma Holdings (CPHI) posted Interest Coverage Ratio of 70.9 for Q1 2026, down 221.2% on a QoQ basis from 22.07 in Q4 2025, and down 161.95% year-over-year from 114.44 in Q1 2025.
China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
China Pharma Holdings' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 70.9 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 161.95% year-over-year to 70.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 30.45 (up 52.44% YoY) and the FY2025 annual result came in at 0.27, up 97.04% from the prior year.
- Interest Coverage Ratio was 70.9 for Q1 2026 at China Pharma Holdings, down from 22.07 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 44.74 in Q4 2023 and bottomed at 70.9 in Q1 2026.
- A 5-year average of 20.19 and a median of 22.43 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 68238.23% — and 2024, when it sank 157419.4%.
- China Pharma Holdings' Interest Coverage Ratio stood at 22.79 in 2022, then surged by 296.31% to 44.74 in 2023, then plunged by 215.18% to 51.53 in 2024, then jumped by 57.16% to 22.07 in 2025, then slumped by 221.2% to 70.9 in 2026.
- Business Quant data shows CPHI's Interest Coverage Ratio at 70.9 in Q1 2026, 22.07 in Q4 2025, and 3.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -70.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.90 |
| Dec 31, 2025 | -22.07 |
| Sep 30, 2025 | -3.03 |
| Jun 30, 2025 | -32.58 |
| Mar 31, 2025 | -27.07 |
| Sep 30, 2024 | -51.53 |
| Jun 30, 2024 | -69.09 |
| Mar 31, 2024 | -39.95 |
| Dec 31, 2023 | 44.74 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -3.31 |
| Mar 31, 2023 | -5.00 |
| Dec 31, 2022 | -22.79 |
| Sep 30, 2022 | -34.33 |
| Jun 30, 2022 | 18.12 |
| Mar 31, 2022 | -4.18 |
| Dec 31, 2021 | -2.65 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | -0.03 |
| Mar 31, 2021 | -0.03 |